Literature DB >> 17296826

Unanswered questions--drug-eluting stents and the risk of late thrombosis.

William H Maisel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17296826     DOI： 10.1056/NEJMp068305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  46 in total

1.  Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practice.

Authors:  Jason C Kovacic; Paul Lee; Rucha Karajgikar; Usman Baber; Birju Narechania; Javed Suleman; Pedro R Moreno; Samin K Sharma; Annapoorna S Kini
Journal:  J Interv Cardiol       Date:  2012-06-22       Impact factor: 2.279

2.  Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease.

Authors:  Ariel Beresniak; Thibaut Caruba; Brigitte Sabatier; Yves Juillière; Olivier Dubourg; Nicolas Danchin
Journal:  World J Cardiol       Date:  2015-10-26

3.  A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study).

Authors:  Jacek Legutko; Wojciech Zasada; Grzegorz L Kałuża; Grzegorz Heba; Lukasz Rzeszutko; Jacek Jakala; Jacek Dragan; Artur Klecha; Dawid Giszterowicz; Wojciech Dobrowolski; Lukasz Partyka; Swaminathan Jayaraman; Dariusz Dudek
Journal:  Indian Heart J       Date:  2013-07-21

4.  Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy.

Authors:  V Puetz; G Gahn; U Becker; D Mucha; A Mueller; N U Weir; B Wiedemann; R von Kummer
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

Review 5.  Contemporary use of clopidogrel in patients with coronary artery disease.

Authors:  Sahil A Parikh; Joshua A Beckman
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

6.  Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.

Authors:  Frederic S Resnic; Arjun Majithia; Sanket S Dhruva; Henry Ssemaganda; Susan Robbins; Danica Marinac-Dabic; Kathleen Hewitt; Lucila Ohno-Machado; Matthew R Reynolds; Michael E Matheny
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-04-14

7.  The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.

Authors:  Amit Kumar; Michael E Matheny; Kalon K L Ho; Robert W Yeh; Thomas C Piemonte; Howard Waldman; Pinak B Shah; Richard Cope; Sharon-Lise T Normand; Sharon Donnelly; Susan Robbins; Frederic S Resnic
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-12-09

8.  Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose.

Authors:  Michela Zanetti; Alessia Stocca; Barbara Dapas; Rossella Farra; Laura Uxa; Alessandra Bosutti; Rocco Barazzoni; Fleur Bossi; Carlo Giansante; Francesco Tedesco; Luigi Cattin; Gianfranco Guarnieri; Gabriele Grassi
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

9.  Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier.

Authors:  Byeongtaek Oh; Russell B Melchert; Chi H Lee
Journal:  Pharm Res       Date:  2015-04-25       Impact factor: 4.200

10.  Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus.

Authors:  Yong-Dan Tang; Ambarish Pandey; Antonina Kolmakova; Xin-Tong Wang; Subbu S Venkatraman; Subroto Chatterjee; Freddy Y C Boey
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.